This does look almost exactly like what you posted last time. But so what?
You are the person I believe that interpreted a DSMB report as somehow being a validation of the MEND trial design - or am I wrong about that?
Beyond doing a part way through the trial check to see that patients aren't actually worse off what does a data safety monitoring board's box checking actually amount to?
That is not a rhetorical question?
Yes its a milestone, but it would be staggeringly surprising to have failed to pass this milestone in my opinion.
Did anybody seriously consider that putting some stem cells into a high tech materials bandage was going to cause patients harm? When in the by now long history of doing a lot of different stuff with MSCs they never have?
CYP Price at posting:
36.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)